Skip to content
FearGreedChartHEALTH

Companies

The companies behind the gauges

Every company in the two gauges and the insurer group, with today’s price and the past 30 days.

Pharma giants

15 companies · pharma gauge

The largest drug makers, worth $50 billion or more each. Steady cash flow and dividends, with patent expiries as the main risk.

Large biotech

10 companies · biotech gauge

Biotech companies with approved drugs and revenue. Big enough for large funds, but still driven by their pipelines.

Smaller biotech

13 companies · biotech gauge

Clinical-stage companies, many without products on the market yet. They feed the breadth and distance-from-high parts of the biotech gauge.

Health insurers

6 companies · compared with XLV

Shown on their own because they move on medical costs, Medicare rates and regulation rather than drug news.

Reference funds

4 funds

Used for comparisons, not counted in the gauges themselves.

Companies no longer listed

The baskets only hold shares that still trade. Amicus Therapeutics (FOLD) left the smaller biotech group when BioMarin completed its purchase in April 2026.